IN FOCUS FEATURE
Teacher Workshops Add New Element to High School Classrooms
FROM OUR WEB SITE
In Focus
Teacher Workshops Add New Element to High School Classrooms
The North Carolina High School Standard Course of Study - the bible of instructional goals for teachers across the state - added biotechnology to its biology curriculum in 2003. The North Carolina Biotechnology Center offers summer workshops for teachers so they can integrate the subject into their daily lessons.
In this week's In Focus, read about this year's workshop offerings, the people who attend, and what they learn.
From Our Web Site
Industrial Fellowship Application Process Now Open
Academic post-doctoral students with an interest in working in industry are invited to apply for this Biotechnology Center-sponsored fellowship.
Regional Grant Deadline Approaching
The North Carolina Biotechnology Center is now accepting applications for its Regional Development Grant Program, which supports economic-development initiatives in communities statewide. The deadline for submissions is August 20.
Wet Lab Space Open at PTRP
Class A wet lab space and incubator space is available in the Piedmont Triad Research Park.
Banner Releases Migraine, Seizure Medication
High Point pharmaceutical company Banner Pharmacaps received approval from the Food and Drug Administration for its new drug application for Valproic Acid Delayed Release soft gelatin capsules.
News from Other Sites
Ethanol plant moving forward
Hoke County's ethanol plant is on schedule for a June 2009 opening.
From the Fayetteville Observer (Paid access)
It's a Good Thing: Martha Stewart Visits N.C. Research Campus
The nationally known lifestyle guru toured the Kannapolis campus and visited the UNC Nutrition Research Institute.
From the Salisbury Post
Scientists: Shape is Key in Nanomedicine
According to UNC-CH scientists, the key to interacting effectively with our bodies' microscopic systems is molding the drugs into the right shape.
From the (Raleigh) News & Observer
Community Watch
- Aldagen, a Durham biopharmaceutical company developing regenerative cell therapies, has appointed William Evans, Pharm.D., to its board of directors. Evans is a director and the chief executive officer of St. Jude Children’s Research Hospital in Memphis, Tenn.
- David King, chief executive officer, president and director of Burlington-based Laboratory Corporation of America, has been elected to the board of directors of the Personalized Medicine Coalition. The coalition includes representatives of more than 140 pharmaceutical, biotechnology, diagnostic, and information technology companies, as well as academic centers and governmental agencies, dedicated to advancing the understanding and adoption of personalized medicine. More
- Metabolon has launched its proprietary biochemicals analysis technology for the bioprocess R&D group at Pfizer’s Global Research and Development division. Headquartered in Research Triangle Park, Metabolon specializes in the use of tools called metabolomics for analyzing complex biological samples for the discovery of markers and pathways associated with drug action and disease.
Please send Community Watch items to Jim Shamp.
September 9-10
BioPharm America 2008
(Atlanta)
October 28
Charlotte Biotechnology Conference
(Charlotte)
December 4-5
SE BIO Investor Forum
(Palm Beach, Fla.)
February 16-17
Biotech 2009
(Raleigh)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, August 7, 2008. For the latest headlines from North Carolina's biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.